Sector Chart Cardiol Therapeutics Inc.

Stocks

CRDL

CA14161Y2006

Biotechnology & Medical Research

Delayed Toronto S.E. 07:36:31 23/09/2026 pm IST			5-day change	1st Jan Change
2.590 ^CAD	-3.00%		-1.15%	+97.71%

13/08	Cardiol Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
12/05	Cardiol Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
CARDIOL THERAPEUTICS INC.	22Cr	-	-	-	-	-
LONZA GROUP AG	4.79TCr
IQVIA HOLDINGS INC.	4.45TCr
BEONE MEDICINES AG	4.19TCr
REVOLUTION MEDICINES, INC.	4.13TCr	-	-	-	-	-
CELLTRION, INC.	3TCr